title: Vaccinia Virus Protein C6 Inhibits Type I IFN Signalling in the Nucleus and Binds to the Transactivation Domain of STAT2.
abstract: The type I interferon (IFN) response is a crucial innate immune signalling pathway required for defense against viral infection. Accordingly, the great majority of mammalian viruses possess means to inhibit this important host immune response. Here we show that vaccinia virus (VACV) strain Western Reserve protein C6, is a dual function protein that inhibits the cellular response to type I IFNs in addition to its published function as an inhibitor of IRF-3 activation, thereby restricting type I IFN production from infected cells. Ectopic expression of C6 inhibits the induction of interferon stimulated genes (ISGs) in response to IFNα treatment at both the mRNA and protein level. C6 inhibits the IFNα-induced Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway at a late stage, downstream of STAT1 and STAT2 phosphorylation, nuclear translocation and binding of the interferon stimulated gene factor 3 (ISGF3) complex to the interferon stimulated response element (ISRE). Mechanistically, C6 associates with the transactivation domain of STAT2 and this might explain how C6 inhibits the type I IFN signalling very late in the pathway. During virus infection C6 reduces ISRE-dependent gene expression despite the presence of the viral protein phosphatase VH1 that dephosphorylates STAT1 and STAT2. The ability of a cytoplasmic replicating virus to dampen the immune response within the nucleus, and the ability of viral immunomodulators such as C6 to inhibit multiple stages of the innate immune response by distinct mechanisms, emphasizes the intricacies of host-pathogen interactions and viral immune evasion.
authors.affiliation: Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
authors.forename: Jennifer H
authors.initials: JH
authors.lastname: Stuart
authors.affiliation: Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
authors.forename: Rebecca P
authors.initials: RP
authors.lastname: Sumner
authors.affiliation: Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
authors.forename: Yongxu
authors.initials: Y
authors.lastname: Lu
authors.affiliation: Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
authors.forename: Joseph S
authors.identifier: http://orcid.org/0000-0001-7857-0634
authors.initials: JS
authors.lastname: Snowden
authors.affiliation: Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
authors.forename: Geoffrey L
authors.identifier: http://orcid.org/0000-0002-3730-9955
authors.initials: GL
authors.lastname: Smith
mesh_terms: D002460:Cell Line; D002467:Cell Nucleus / Q000276:immunology / Q000378:metabolism; D005434:Flow Cytometry; D054884:Host-Pathogen Interactions / Q000502:physiology*; D006801:Humans; D007113:Immunity, Innate; D047468:Immunoprecipitation; D007370:Interferon Type I / Q000276:immunology* / Q000378:metabolism; D018613:Microscopy, Confocal; D060888:Real-Time Polymerase Chain Reaction; D050795:STAT2 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction / Q000276:immunology; D015533:Transcriptional Activation; D014616:Vaccinia virus / Q000276:immunology* / Q000378:metabolism; D014764:Viral Proteins / Q000276:immunology*
chemical_list: D007370:Interferon Type I; D050795:STAT2 Transcription Factor; C494084:STAT2 protein, human; D014764:Viral Proteins